Changing the paradigm of how IBD and other autoimmune diseases are treated
We’re Prometheus Biosciences, an innovative biotechnology company performing groundbreaking science to discover and develop novel therapeutic and companion diagnostic product candidates for the treatment of immune-mediated diseases, starting first with inflammatory bowel disease (IBD).
Our transformational approach brings the power of big data to immune biology, changing lives through patient-centric drug design.
Our mission: to revolutionize autoimmune medicine with precision
Our vision: to utilize targeted medicine to improve the quality of life of people with GI and immune-mediated diseases